Insight 22
Can medications cause hair loss?
Last reviewed
Published
Updated
Hair loss may begin after a new prescription, a dose change or years of treatment. The timing can be difficult to connect. The health condition being treated may also affect hair, and several causes can occur together.
A useful review brings the drug history and scalp findings together. It should explain whether treatment is contributing and how to protect your hair while maintaining care for your health.
The delay can hide the connection
Some drugs interrupt active hair growth and cause loss within weeks. Others move more hairs toward shedding, with the change becoming visible two to four months later. Longer delays have also been reported. A small valproate case series described hair loss after one to three years of use.1
A drug you have taken for a long time still belongs in the history. Include dose changes and treatment interruptions, along with illness, weight changes and the first photographs showing a difference.
The date hair loss becomes visible may be months after the change that started it.
Different drugs can produce different changes
Antidepressants, including SSRIs and SNRIs, and neurological treatments such as valproate belong in a medication review. A large study comparing antidepressants found differences in recorded hair-loss risk between drugs. That helps guide a review of alternatives with the prescriber.1,2
An isolated report carries less weight than a repeated finding across studies. Hair loss has been reported with the acid-reducing drug omeprazole and with statins. The rosuvastatin report also notes that larger studies have found no significant association with statin use. The exact drug, timing and examination determine how much weight to give the possibility.3,4
Immune treatment can create an unexpected scalp problem
Biologic drugs target parts of the immune system. Some TNF inhibitors used for inflammatory diseases can trigger a new scalp reaction with scale and hair loss. Published cases describe reactions months or years into treatment. The appearance can overlap with psoriasis or alopecia areata.5
New patches, soreness or scale deserve examination. Trichoscopy and sometimes a biopsy help distinguish a drug reaction from a separate scalp disorder. That distinction informs whether the prescriber treats the scalp, adjusts treatment or selects an alternative.5
A growth treatment can also increase shedding
Starting minoxidil can temporarily increase shedding as hair cycling changes. Research has documented this early effect. Its timing and course need to fit the treatment history. Persistent loss or new scalp symptoms require reassessment.6
This matters when several treatments begin together. Without a record of the starting point, an early shed can be mistaken for worsening disease or failure of the whole plan.
Make the review useful to your prescriber
Bring a complete list of prescriptions, over-the-counter drugs and supplements, with doses and dates. Include treatments you have stopped. Photographs and pharmacy records can help rebuild an uncertain timeline.
Arrange changes with the prescriber. Abruptly stopping an antidepressant, seizure treatment or immune therapy can create other health problems. The plan should name the suspected contributor, explain the options and set a follow-up point. Hair recovery may take months, and an underlying pattern of thinning may need its own treatment.
At FHI, I assess how the history fits the hair and scalp findings, then provide recommendations for the patient and treating prescriber.
References
- Sodium Valproate Induced Alopecia: A Case Series. J Clin Diagn Res. 2017. doi:10.7860/JCDR/2017/28564.10658. Return to text ↑
- Etminan M, et al. Risk of hair loss with different antidepressants: a comparative retrospective cohort study. Int Clin Psychopharmacol. 2018;33:44–48. doi:10.1097/YIC.0000000000000191. Return to text ↑
- Diffuse alopecia associated with omeprazole. Published case report. PubMed PMID:9317099. Return to text ↑
- Ohnishi Y, et al. Alopecia Associated with Rosuvastatin. Intern Med. doi:10.2169/internalmedicine.3569-24. Return to text ↑
- Liu L, et al. Psoriatic Alopecia/Alopecia Areata-Like Reactions Secondary to Anti-Tumour Necrosis Factor-Alpha Therapy. Australas J Dermatol. 2025;66:e461–e465. doi:10.1111/ajd.14591. Return to text ↑
- Nohria A, et al. Combating dread shed: The impact of overlapping topical and oral minoxidil on temporary hair shedding during oral minoxidil initiation. JAAD Int. 2024;15:220–224. PubMed PMID:38707927. Return to text ↑
